Status:
COMPLETED
Glucomannan for the Treatment of Abdominal Pain-related Functional Gastrointestinal Disorders in Childhood
Lead Sponsor:
Medical University of Warsaw
Conditions:
Functional Gastrointestinal Disorders
Eligibility:
All Genders
8-18 years
Phase:
PHASE4
Brief Summary
Background: Functional abdominal pain disorders (FAPD) are common in school-aged children; however, there is no reliable treatment. Aim: To determine the efficacy and safety of glucomannan for treati...
Detailed Description
According to the Rome III criteria, abdominal pain-related functional gastrointestinal disorders (FGD) in children may be categorised as functional dyspepsia (FD), irritable bowel syndrome (IBS), abdo...
Eligibility Criteria
Inclusion
- abdominal pain related disorder (functional dyspepsia, irritable bowel syndrome or functional abdominal pain (FAPS) diagnosed according to Rome III criteria.
Exclusion
- organic gastrointestinal disease (as established by medical history, complete blood count, urinalysis, stool examination for occult blood, ova and parasites, blood chemistries, abdominal ultrasound, breath hydrogen testing and endoscopy, if needed)
- other chronic disease
- growth failure
Key Trial Info
Start Date :
January 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2012
Estimated Enrollment :
89 Patients enrolled
Trial Details
Trial ID
NCT01495806
Start Date
January 1 2010
End Date
January 1 2012
Last Update
July 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dpt of Pediatrics Warsaw Medical University
Warsaw, Warsaw, Poland, 01-410